Loading...
Pfizer's Future Depends on Oncology Growth, New Products and operational efficiency
n/a
n/a
Francisco's Fair Value
n/a
1Y
-2.6%7D
5.0%1Y
-2.6%7D
5.0%You can edit this narrative until May 14 2:32 AM. Then, changes will post as Updates.
You can edit this narrative until May 14 2:32 AM. Then, changes will post as Updates.